Cargando…
Identification of early and distinct glioblastoma response patterns treated by boron neutron capture therapy not predicted by standard radiographic assessment using functional diffusion map
BACKGROUND: Radiologic response of brain tumors is traditionally assessed according to the Macdonald criteria 10 weeks from the start of therapy. Because glioblastoma (GB) responds in days rather than weeks after boron neutron capture therapy (BNCT) that is a form of tumor-selective particle radiati...
Autores principales: | Hiramatsu, Ryo, Kawabata, Shinji, Furuse, Motomasa, Miyatake, Shin-Ichi, Kuroiwa, Toshihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751226/ https://www.ncbi.nlm.nih.gov/pubmed/23915330 http://dx.doi.org/10.1186/1748-717X-8-192 |
Ejemplares similares
-
Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
por: Miyatake, Shin-Ichi, et al.
Publicado: (2014) -
Boron Neutron Capture Therapy for Malignant Brain Tumors
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2016) -
RT-06 PLANNING OF BORON NEUTRON CAPTURE THERAPY (BNCT) USING POSITRON EMISSION TOMOGRAPHY (PET)
por: Kawabata, Shinji, et al.
Publicado: (2019) -
Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas – A Pilot Study
por: SHIBA, Hiroyuki, et al.
Publicado: (2018) -
ET-5 Biological effects of simultaneous use of multiple drugs in neutron capture therapy using rat brain tumor model
por: Kawabata, Shinji, et al.
Publicado: (2021)